1 453 125 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 2 496 49 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018 3 831 43 EFFECT OF YOGA ON MIGRAINE: A COMPREHENSIVE STUDY USING CLINICAL PROFILE AND CARDIAC AUTONOMIC FUNCTIONS. CONTEXT AND AIMS: MIGRAINE IS AN EPISODIC DISABLING HEADACHE REQUIRING LONG-TERM MANAGEMENT. MIGRAINE MANAGEMENT THROUGH YOGA THERAPY WOULD REDUCE THE MEDICATION COST WITH POSITIVE HEALTH BENEFITS. YOGA HAS SHOWN TO IMPROVE THE QUALITY OF LIFE, REDUCE THE EPISODE OF HEADACHE AND MEDICATION. THE AIM OF THE PRESENT STUDY WAS TO EVALUATE THE EFFICACY OF YOGA AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS BY ASSESSING CLINICAL OUTCOME AND AUTONOMIC FUNCTIONS TESTS. SUBJECTS AND METHODS: MIGRAINE PATIENTS WERE RANDOMLY GIVEN EITHER CONVENTIONAL CARE (N = 30) OR YOGA WITH CONVENTIONAL CARE (N = 30). YOGA GROUP RECEIVED YOGA PRACTICE SESSION FOR 5 DAYS A WEEK FOR 6 WEEKS ALONG WITH CONVENTIONAL CARE. CLINICAL ASSESSMENT (FREQUENCY, INTENSITY OF HEADACHE AND HEADACHE IMPACT) AND AUTONOMIC FUNCTION TEST WERE DONE AT BASELINE AND AT THE END OF THE INTERVENTION. RESULTS: YOGA WITH CONVENTIONAL CARE AND CONVENTION CARE GROUPS SHOWED SIGNIFICANT IMPROVEMENT IN CLINICAL VARIABLES, BUT IT WAS BETTER WITH YOGA THERAPY. IMPROVEMENT IN THE VAGAL TONE ALONG WITH REDUCED SYMPATHETIC ACTIVITY WAS OBSERVED IN PATIENTS WITH MIGRAINE RECEIVING YOGA AS ADJUVANT THERAPY. CONCLUSIONS: INTERVENTION SHOWED SIGNIFICANT CLINICAL IMPROVEMENT IN BOTH GROUPS. HEADACHE FREQUENCY AND INTENSITY WERE REDUCED MORE IN YOGA WITH CONVENTIONAL CARE THAN THE CONVENTIONAL CARE GROUP ALONE. FURTHERMORE, YOGA THERAPY ENHANCED THE VAGAL TONE AND DECREASED THE SYMPATHETIC DRIVE, HENCE IMPROVING THE CARDIAC AUTONOMIC BALANCE. THUS, YOGA THERAPY CAN BE EFFECTIVELY INCORPORATED AS AN ADJUVANT THERAPY IN MIGRAINE PATIENTS. 2014 4 2702 30 YOGA INTERVENTION ON BLOOD NO IN FEMALE MIGRAINEURS. BACKGROUND: THE CURRENT SURVEY INVESTIGATES THE EFFECT OF 12 WEEKS YOGA TRAINING ON HEADACHE FREQUENCY, SEVERITY, DURATION AND BLOOD NITRIC OXIDE LEVELS AS WELL AS HEADACHE IMPACTS ON FEMALE MIGRAINEURS' LIVES. MATERIALS AND METHODS: THIRTY-TWO FEMALE PATIENTS WITH MIGRAINE TOOK PART AND WERE RANDOMLY DIVIDED INTO TWO GROUPS. THE CONTROL GROUP (N = 14) RECEIVED MEDICATION AND THE YOGA GROUP (N = 18) PARTICIPATED IN 12 WEEKS YOGA TRAINING IN ADDITION TO RECEIVING THE SAME MEDICATION AS THAT OF THE CONTROL GROUP. FREQUENCY AND DURATION OF HEADACHE WERE ASSESSED BY A QUESTIONNAIRE. VISUAL ANALOGUE SCALE WAS USED TO MEASURE THE SEVERITY OF HEADACHE, AND THE METABOLITE OF NO ALSO WAS MEASURED BY GRIESS REACTION. HEADACHE IMPACT TEST (HIT-6) WAS ALSO USED TO ASSESS THE IMPACT OF HEADACHE ON PATIENTS' LIVES. DATA WERE ANALYZED BY T-TEST MEAN VARIANCE. RESULTS: AFTER 3 MONTHS INTERVENTION, IN THE YOGA GROUP, THERE WAS A SIGNIFICANT REDUCTION IN THE IMPACT OF HEADACHE ON PATIENTS' LIVES, HEADACHE FREQUENCY, AND SEVERITY AND A NON-SIGNIFICANT REDUCTION IN HEADACHE DURATION IN THE YOGA GROUP. THERE WAS NO SIGNIFICANT DIFFERENCE IN THE PLASMA LEVELS OF NO BETWEEN YOGA AND CONTROL GROUPS BEFORE AND AFTER THE STUDY. CONCLUSION: BASED ON THE RESULTS, YOGA COULD BE RECOMMENDED AS A COMPLEMENTARY METHOD TO MIGRAINE PATIENTS. 2015 5 933 37 EFFECTIVENESS OF YOGA THERAPY IN THE TREATMENT OF MIGRAINE WITHOUT AURA: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: NUMEROUS STUDIES HAVE EXPLORED THE EFFECTIVENESS OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN THE TREATMENT OF MIGRAINE BUT THERE IS NO DOCUMENTED INVESTIGATION OF THE EFFECTIVENESS OF YOGA THERAPY FOR MIGRAINE MANAGEMENT. OBJECTIVES: TO INVESTIGATE THE EFFECTIVENESS OF HOLISTIC APPROACH OF YOGA THERAPY FOR MIGRAINE TREATMENT COMPARED TO SELF-CARE. DESIGN: A RANDOMIZED CONTROLLED TRIAL. METHODS: SEVENTY-TWO PATIENTS WITH MIGRAINE WITHOUT AURA WERE RANDOMLY ASSIGNED TO YOGA THERAPY OR SELF-CARE GROUP FOR 3 MONTHS. PRIMARY OUTCOMES WERE HEADACHE FREQUENCY (HEADACHE DIARY), SEVERITY OF MIGRAINE (0-10 NUMERICAL SCALE) AND PAIN COMPONENT (MCGILL PAIN QUESTIONNAIRE). SECONDARY OUTCOMES WERE ANXIETY AND DEPRESSION (HOSPITAL ANXIETY DEPRESSION SCALE), MEDICATION SCORE. RESULTS: AFTER ADJUSTMENT FOR BASELINE VALUES, THE SUBJECTS' COMPLAINTS RELATED TO HEADACHE INTENSITY (P < .001), FREQUENCY (P < .001), PAIN RATING INDEX (P < .001), AFFECTIVE PAIN RATING INDEX (P < .001), TOTAL PAIN RATING INDEX (P < .001), ANXIETY AND DEPRESSION SCORES (P < .001), SYMPTOMATIC MEDICATION USE (P < .001) WERE SIGNIFICANTLY LOWER IN THE YOGA GROUP COMPARED TO THE SELF-CARE GROUP. CONCLUSION: THE STUDY DEMONSTRATED A SIGNIFICANT REDUCTION IN MIGRAINE HEADACHE FREQUENCY AND ASSOCIATED CLINICAL FEATURES, IN PATIENTS TREATED WITH YOGA OVER A PERIOD OF 3 MONTHS. FURTHER STUDY OF THIS THERAPEUTIC INTERVENTION APPEARS TO BE WARRANTED. 2007 6 2003 37 STUDY OF ADDITIVE EFFECT OF YOGA AND PHYSICAL THERAPIES TO STANDARD PHARMACOLOGIC TREATMENT IN MIGRAINE. OBJECTIVE WE AIMED TO EVALUATE AND COMPARE THE EFFECTIVENESS OF PHYSICAL AND YOGA THERAPIES AS AN ADJUVANT THERAPY ALONG WITH STANDARD PHARMACOLOGIC TREATMENT IN PATIENTS WITH MIGRAINE. MATERIALS AND METHODS A TOTAL OF 61 CONSENTING PATIENTS DIAGNOSED TO HAVE MIGRAINE WERE RANDOMIZED INTO THREE GROUPS TO RECEIVE EITHER STANDARD TREATMENT ALONE, PHYSICAL THERAPY ALONG WITH STANDARD TREATMENT, OR YOGA THERAPY ALONG WITH STANDARD TREATMENT. THE RESPECTIVE ADJUVANT INTERVENTION WAS TAUGHT TO THE RESPECTIVE GROUP OF PATIENTS AND THEY WERE ADVISED TO PERFORM IT DAILY FOR 3 MONTHS WITH WEEKLY TELEPHONIC REMINDERS AND REVIEW OF THEIR ACTIVITY LOGS. OUTCOME MEASURES ASSESSED WERE HEADACHE FREQUENCY, SHORT-FORM MCGILL PAIN QUESTIONNAIRE (SF-MPQ), AND HEADACHE IMPACT TEST-6 (HIT-6) AT RECRUITMENT AND ONCE EVERY MONTH FOR 3 MONTHS. STATISTICAL ANALYSIS STATISTICAL ANALYSIS OF THE STUDY WAS DONE BY USING STATA 14.1 SOFTWARE. ALL THE DESCRIPTIVE STATISTICS, PAIRED T -TEST WAS USED TO COMPARE THE DIFFERENCE BETWEEN PRE AND POSTINTERVENTION VALUES OF HEADACHE FREQUENCY, SF-MPQ, AND HIT-6 SCORE WITHIN ALL THE THREE GROUPS. ANALYSIS OF VARIANCE TEST AND POST HOC TEST WERE USED TO COMPARE THE DIFFERENCES BETWEEN ALL GROUPS FOR OUTCOME MEASURES ( P < 0.05). RESULTS HEADACHE FREQUENCY AND THE VISUAL ANALOG SCALE BEFORE INTERVENTION COMPARED DURING EACH MONTH INTERVALS FOR 3 MONTHS IN ALL THE THREE GROUPS WERE SIGNIFICANTLY DECREASED IN ALL THE THREE GROUPS ( P < 0.005). YOGA OR PHYSICAL THERAPY AS AN ADJUVANT TO STANDARD TREATMENT LEADS TO A HIGHER REDUCTION IN HEADACHE FREQUENCY AND SEVERITY. SENSORY AND AFFECTIVE PAIN RATINGS OF SF-MPQ AND HIT-6 ALSO SHOWED A SIGNIFICANT IMPROVEMENT AT 1 TO 3 MONTHS OF TREATMENT COMPARED WITH BASELINE IN ALL THE THREE GROUPS. CONCLUSION EITHER PHYSICAL OR YOGA THERAPY AS AN ADJUVANT TO STANDARD PHARMACOLOGIC TREATMENT MAY FURTHER IMPROVE THE QUALITY OF LIFE AND REDUCE HEADACHE FREQUENCY IN PATIENTS WITH MIGRAINE. 2021 7 1318 40 HEART RATE VARIABILITY IN CHRONIC LOW BACK PAIN PATIENTS RANDOMIZED TO YOGA OR STANDARD CARE. BACKGROUND: CHRONIC PAIN CAN ALTER THE AUTONOMIC BALANCE WITH INCREASED SYMPATHETIC ACTIVITY REFLECTED IN ALTERED HEART RATE VARIABILITY (HRV). IT HAS BEEN PROPOSED THAT YOGA CAN BE USEFUL TO CORRECT THE AUTONOMIC IMBALANCE IN PATIENTS WITH CHRONIC PAIN WHO HAVE REDUCED HRV. METHODS AND DESIGNS: IN THE PRESENT RANDOMIZED CONTROLLED TRIAL 62 PATIENTS WITH CHRONIC LOW BACK PAIN ASSOCIATED WITH ALTERED ALIGNMENT OF INTERVERTEBRAL DISCS (AGED BETWEEN 20 AND 45 YEARS, 32 MALES) WERE RANDOMIZED TO 2 GROUPS. ONE GROUP RECEIVED YOGA FOR 3 MONTHS WHILE THE OTHER GROUP CARRIED OUT STANDARD MEDICAL CARE BASED ON THE PHYSICIAN'S ADVICE. THE DURATION WAS THE SAME, I.E., 3 MONTHS. THE HEART RATE VARIABILITY AND RATE OF RESPIRATION WERE ASSESSED AT BASELINE AND AT THE END OF 3 MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE IN THE BASELINE (PRE) VALUES BETWEEN GROUPS (P = 0.008) FOR RESPIRATION RATE WHICH WAS HIGHER IN THE YOGA GROUP. THE CHANGES REPORTED BELOW ARE PRE-POST COMPARISONS WITHIN EACH GROUP. THE YOGA GROUP SHOWED A SIGNIFICANT (P < 0.05; REPEATED MEASURES ANOVA, POST-HOC ANALYSES) DECREASE IN THE LF POWER OF HRV, RATE OF RESPIRATION AND A SIGNIFICANT INCREASE IN THE HF POWER OF HRV AND IN THE PNN50. CONCLUSION: THE RESULTS SUGGEST THAT YOGA PRACTICE CAN SHIFT THE AUTONOMIC BALANCE TOWARDS VAGAL DOMINANCE IN PATIENTS WITH CHRONIC LOW BACK PAIN ASSOCIATED WITH ALTERED ALIGNMENT OF INTERVERTEBRAL DISCS. TRIAL REGISTRATION: THE STUDY IS REGISTERED WITH THE CLINICAL TRIALS REGISTRY OF INDIA ( CTRI/2012/11/003094 ) AND CAN BE ACCESSED AT. 2016 8 871 45 EFFECT OF YOGA THERAPY ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HEART RATE VARIABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS. BACKGROUND: RHEUMATOID ARTHRITIS (RA) IS AN IMMUNE-MEDIATED INFLAMMATORY DISEASE. ANTIRHEUMATOID TREATMENT REDUCES DISEASE ACTIVITY AND INFLAMMATION, BUT NOT ALL PATIENTS RESPOND TO TREATMENT. AUTONOMIC DYSFUNCTION IS COMMON IN RA LEADING TO FREQUENT CARDIOVASCULAR COMPLICATIONS. YOGA THERAPY MAY BE USEFUL IN THESE PATIENTS, BUT THERE ARE LITTLE DATA ON THE EFFECT OF YOGA ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HEART RATE VARIABILITY (HRV). OBJECTIVES: THIS STUDY ASSESSED THE EFFECT OF 12-WEEK YOGA THERAPY ON DISEASE ACTIVITY, INFLAMMATORY MARKERS, AND HRV IN PATIENTS WITH RA. MATERIALS AND METHODS: THIS RANDOMIZED CONTROL TRIAL WAS CONDUCTED ON NEWLY DIAGNOSED RA PATIENTS ATTENDING OUTPATIENT SERVICES AT THE DEPARTMENT OF CLINICAL IMMUNOLOGY, JIPMER. ONE HUNDRED AND SIXTY-SIX PARTICIPANTS WERE RANDOMIZED INTO TWO GROUPS: THE CONTROL GROUP (CG) (N = 83) AND YOGA GROUP (YG) (N = 83). YOGA THERAPY WAS ADMINISTERED TO PARTICIPANTS IN THE YG FOR 12 WEEKS, ALONG WITH STANDARD MEDICAL TREATMENT. THE CG RECEIVED ONLY STANDARD MEDICAL TREATMENT. PRIMARY OUTCOMES WERE DISEASE ACTIVITY SCORE 28, INTERLEUKIN-1ALPHA (IL-1ALPHA), IL-6, TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA), CORTISOL, AND HRV PARAMETERS. ALL PARAMETERS WERE MEASURED AT BASELINE AND AFTER 12 WEEKS. RESULTS: DISEASE ACTIVITY SIGNIFICANTLY DECREASED IN BOTH GROUPS AFTER 12 WEEKS, BUT IT WAS REDUCED MORE IN YG, WHICH WAS STATISTICALLY SIGNIFICANT (P < 0.05). IN BOTH YG AND CG, IL-1ALPHA, IL-6, TNF-ALPHA, AND CORTISOL DECREASED AFTER 12 WEEKS, BUT IL-1ALPHA AND CORTISOL DECREASED MORE SIGNIFICANTLY IN YG THAN IN CG. LOW-FREQUENCY COMPONENT EXPRESSED AS NORMALIZED UNIT (LFNU) AND THE LOW-FREQUENCY/HIGH-FREQUENCY (LF-HF) RATIO DECREASED SIGNIFICANTLY, AND TOTAL POWER AND HF COMPONENT EXPRESSED AS NORMALIZED UNIT (HFNU) INCREASED SIGNIFICANTLY IN THE YG COMPARED WITH CG. CONCLUSION: TWELVE-WEEK YOGA THERAPY, IF GIVEN ALONG WITH STANDARD MEDICAL TREATMENT, SIGNIFICANTLY REDUCES DISEASE ACTIVITY AND IMPROVES SYMPATHOVAGAL BALANCE IN RA PATIENTS. 2020 9 1062 33 EFFECTS OF YOGA ON HEART RATE VARIABILITY AND DEPRESSIVE SYMPTOMS IN WOMEN: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THE PURPOSE OF THE STUDY WAS TO INVESTIGATE THE EFFECTS OF A 12-WEEK YOGA PROGRAM ON HEART RATE VARIABILITY (HRV) AND DEPRESSIVE SYMPTOMS IN DEPRESSED WOMEN. METHODS: THIS WAS A RANDOMIZED CONTROLLED TRIAL. TWENTY-SIX SEDENTARY WOMEN SCORING >/=14 ON THE BECK DEPRESSION INVENTORY-II WERE RANDOMIZED TO EITHER THE YOGA OR THE CONTROL GROUP. THE YOGA GROUP COMPLETED A 12-WEEK YOGA PROGRAM, WHICH TOOK PLACE TWICE A WEEK FOR 60 MIN PER SESSION AND CONSISTED OF BREATHING EXERCISES, YOGA POSE PRACTICE, AND SUPINE MEDITATION/RELAXATION. THE CONTROL GROUP WAS INSTRUCTED NOT TO ENGAGE IN ANY YOGA PRACTICE AND TO MAINTAIN THEIR USUAL LEVEL OF PHYSICAL ACTIVITY DURING THE COURSE OF THE STUDY. PARTICIPANTS' HRV, DEPRESSIVE SYMPTOMS, AND PERCEIVED STRESS WERE ASSESSED AT BASELINE AND POST-TEST. RESULTS: THE YOGA GROUP HAD A SIGNIFICANT INCREASE IN HIGH-FREQUENCY HRV AND DECREASES IN LOW-FREQUENCY HRV AND LOW FREQUENCY/HIGH FREQUENCY RATIO AFTER THE INTERVENTION. THE YOGA GROUP ALSO REPORTED SIGNIFICANTLY REDUCED DEPRESSIVE SYMPTOMS AND PERCEIVED STRESS. NO CHANGE WAS FOUND IN THE CONTROL GROUP. CONCLUSIONS: A 12-WEEK YOGA PROGRAM WAS EFFECTIVE IN INCREASING PARASYMPATHETIC TONE AND REDUCING DEPRESSIVE SYMPTOMS AND PERCEIVED STRESS IN WOMEN WITH ELEVATED DEPRESSIVE SYMPTOMS. REGULAR YOGA PRACTICE MAY BE RECOMMENDED FOR WOMEN TO COPE WITH THEIR DEPRESSIVE SYMPTOMS AND STRESS AND TO IMPROVE THEIR HRV. 2017 10 452 41 CHANGES IN HEART RATE VARIABILITY AFTER YOGA ARE DEPENDENT ON HEART RATE VARIABILITY AT BASELINE AND DURING YOGA: A STUDY SHOWING AUTONOMIC NORMALIZATION EFFECT IN YOGA-NAIVE AND EXPERIENCED SUBJECTS. BACKGROUND: YOGA THERAPY IS WIDELY APPLIED TO THE MAINTENANCE OF HEALTH AND TO TREATMENT OF VARIOUS ILLNESSES. PREVIOUS RESEARCHES INDICATE THE INVOLVEMENT OF AUTONOMIC CONTROL IN ITS EFFECTS, ALTHOUGH THE GENERAL AGREEMENT HAS NOT BEEN REACHED REGARDING THE ACUTE MODULATION OF AUTONOMIC FUNCTION. AIM: THE PRESENT STUDY AIMED AT REVEALING THE ACUTE EFFECT OF YOGA ON THE AUTONOMIC ACTIVITY USING HEART RATE VARIABILITY (HRV) MEASUREMENT. METHODS: TWENTY-SEVEN HEALTHY CONTROLS PARTICIPATED IN THE PRESENT STUDY. FIFTEEN OF THEM (39.5 +/- 8.5 YEARS OLD) WERE NAIVE AND 12 (45.1 +/- 7.0 YEARS OLD) WERE EXPERIENCED IN YOGA. YOGA SKILLS INCLUDED BREATH AWARENESS, TWO TYPES OF ASANA, AND TWO TYPES OF PRANAYAMA. HRV WAS MEASURED AT THE BASELINE, DURING YOGA, AND AT THE RESTING STATE AFTER YOGA. RESULTS: IN BOTH YOGA-NAIVE AND EXPERIENCED PARTICIPANTS, THE CHANGES IN LOW-FREQUENCY (LF) COMPONENT OF HRV AND ITS RATIO TO HIGH-FREQUENCY (HF) COMPONENT (LF/HF) AFTER YOGA WERE FOUND TO BE CORRELATED NEGATIVELY WITH THE BASELINE DATA. THE CHANGES IN LF AFTER YOGA WERE ALSO CORRELATED WITH LF DURING YOGA. THE CHANGES IN HF AS WELL AS THE RAW HRV DATA AFTER YOGA WERE NOT RELATED TO THE BASELINE HRV OR THE HRV DURING YOGA. CONCLUSION: THE RESULTS INDICATE THAT YOGA LEADS TO AN INCREASE IN LF WHEN LF IS LOW AND LEADS TO A DECREASE IN LF WHEN IT IS HIGH AT THE BASELINE. THIS NORMALIZATION OF LF IS DEPENDENT ON THE AUTONOMIC MODULATION DURING YOGA AND MAY UNDERLIE THE CLINICAL EFFECTIVENESS OF YOGA THERAPY BOTH IN YOGA-NAIVE AND EXPERIENCED SUBJECTS. 2020 11 1076 33 EFFECTS OF YOGA ON PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING IN MULTIPLE SCLEROSIS PATIENTS: A RANDOMIZED TRIAL. INTRODUCTION: MULTIPLE SCLEROSIS (MS) AS A CHRONIC DISEASE COULD AFFECT PATIENTS' VARIOUS DOMAINS OF LIFE. AIM: THIS STUDY WAS CONDUCTED TO STUDY THE EFFECT OF YOGA ON THE PHYSIOLOGICAL INDICES, ANXIETY AND SOCIAL FUNCTIONING OF PATIENTS WITH MS IN SOUTHWEST, IRAN. MATERIALS AND METHODS: IN THIS CLINICAL TRIAL STUDY, 60 MS PATIENTS WERE ENROLLED ACCORDING TO INCLUSION CRITERIA AND RANDOMLY ASSIGNED TO TWO GROUPS OF 30 EACH. PRIOR TO AND AFTER INTERVENTION, THE PATIENTS' VITAL SIGNS WERE MEASURED. FOR CASE GROUP YOGA EXERCISES WERE PERFORMED THREE SESSIONS A WEEK FOR 12 WEEKS WHILE CONTROL GROUP PERFORMED NO EXERCISE. THE DATA WERE GATHERED BY QUESTIONNAIRE AND ANALYSED BY DESCRIPTIVE AND ANALYTICAL STATISTICS IN SPSS. RESULTS: PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN FATIGUE SEVERITY AND PAIN BETWEEN THE TWO GROUPS BUT THE MEAN FATIGUE SEVERITY AND PAIN IN CASE GROUP DECREASED COMPARED TO THE CONTROL GROUP AFTER THE INTERVENTION. PRIOR TO INTERVENTION, THERE WAS NO SIGNIFICANT DIFFERENCE IN MEAN PHYSIOLOGICAL INDICES BETWEEN THE TWO GROUPS BUT THE MEAN PHYSIOLOGICAL INDICES IN CASE GROUP DECREASED SIGNIFICANTLY AFTER THE INTERVENTION (P<0.05). CONCLUSION: YOGA IS LIKELY TO INCREASE SELF-EFFICACY OF MS PATIENTS THROUGH ENHANCING PHYSICAL ACTIVITY, INCREASING THE STRENGTH OF LOWER LIMBS AND BALANCE, AND DECREASING FATIGUE AND PAIN, AND FINALLY TO PROMOTE SOCIAL FUNCTIONING AND TO RELIEVE STRESS AND ANXIETY IN THESE PATIENTS. 2016 12 306 40 AN EVALUATION OF THE ABILITY TO VOLUNTARILY REDUCE THE HEART RATE AFTER A MONTH OF YOGA PRACTICE. THE STUDY AIMED AT DETERMINING WHETHER NOVICES TO YOGA WOULD BE ABLE TO REDUCE THEIR HEART RATE VOLUNTARILY AND WHETHER THE MAGNITUDE OF REDUCTION WOULD BE MORE AFTER 30 DAYS OF YOGA TRAINING. TWO GROUPS (YOGA AND CONTROL, N = 12 EACH) WERE ASSESSED ON DAY 1 AND ON DAY 30. DURING THE INTERVENING 30 DAYS, THE YOGA GROUP RECEIVED TRAINING IN YOGA TECHNIQUES WHILE THE CONTROL GROUP CARRIED ON WITH THEIR ROUTINE. AT EACH ASSESSMENT THE BASELINE HEART RATE WAS RECORDED FOR ONE MINUTE, THIS WAS FOLLOWED BY A SIX-MINUTE PERIOD DURING WHICH PARTICIPANTS WERE ASKED TO ATTEMPT TO VOLUNTARILY REDUCE THEIR HEART RATE, USING ANY STRATEGY. BOTH THE BASELINE HEART RATE AND THE LOWEST HEART RATE ACHIEVED VOLUNTARILY DURING THE SIX-MINUTE PERIOD WERE SIGNIFICANTLY LOWER IN THE YOGA GROUP ON DAY 30 COMPARED TO DAY 1 BY A GROUP AVERAGE OF 10.7 BEATS PER MINUTE (I.E., BPM) AND 6.8 BPM, RESPECTIVELY (P < .05, WILCOXON PAIRED SIGNED RANKS TEST). IN CONTRAST, THERE WAS NO SIGNIFICANT CHANGE IN EITHER THE BASELINE HEART RATE OR THE LOWEST HEART RATE ACHIEVED VOLUNTARILY IN THE CONTROL GROUP ON DAY 30 COMPARED TO DAY 1. THE RESULTS SUGGEST THAT YOGA TRAINING CAN ENABLE PRACTITIONERS TO USE THEIR OWN STRATEGIES TO REDUCE THE HEART RATE, WHICH HAS POSSIBLE THERAPEUTIC APPLICATIONS. 2004 13 297 34 ALTERNATE NOSTRIL BREATHING AT DIFFERENT RATES AND ITS INFLUENCE ON HEART RATE VARIABILITY IN NON PRACTITIONERS OF YOGA. INTRODUCTION: HEART RATE VARIABILITY IS A MEASURE OF MODULATION IN AUTONOMIC INPUT TO THE HEART AND IS ONE OF THE MARKERS OF AUTONOMIC FUNCTIONS. THOUGH THERE ARE MANY STUDIES ON THE LONG TERM INFLUENCE OF BREATHING ON HRV (HEART RATE VARIABILITY) THERE ARE ONLY A FEW STUDIES ON THE IMMEDIATE EFFECT OF BREATHING ESPECIALLY ALTERNATE NOSTRIL BREATHING ON HRV. THIS STUDY FOCUSES ON THE IMMEDIATE EFFECTS OF ALTERNATE NOSTRIL BREATHING AND THE INFLUENCE OF DIFFERENT BREATHING RATES ON HRV. MATERIALS AND METHODS: THE STUDY WAS DONE ON 25 SUBJECTS IN THE AGE GROUP OF 17-35 YEARS. ECG AND RESPIRATION WERE RECORDED BEFORE INTERVENTION AND IMMEDIATELY AFTER THE SUBJECTS WERE ASKED TO PERFORM ALTERNATE NOSTRIL BREATHING FOR FIVE MINUTES. RESULTS: LOW FREQUENCY (LF) WHICH IS A MARKER OF SYMPATHETIC ACTIVITY INCREASED, HIGH FREQUENCY (HF) WHICH IS A MARKER OF PARASYMPATHETIC ACTIVITY DECREASED AND THEIR RATIO LF/HF WHICH IS A MARKER OF SYMPATHO/VAGAL BALANCE INCREASED IMMEDIATELY AFTER 6 AND 12 MINUTES IN COMPARISON TO BASELINE VALUES WHEREAS THERE WAS NO SIGNIFICANT DIFFERENCE IN THE MEANS OF THESE COMPONENTS WHEN BOTH 6 AND 12 MINUTES WERE COMPARED. CONCLUSION: IMMEDIATE EFFECTS OF ALTERNATE NOSTRIL BREATHING ON HRV IN NON PRACTITIONERS OF YOGIC BREATHING ARE VERY DIFFERENT FROM THE LONG TERM INFLUENCE OF YOGIC BREATHING ON HRV WHICH SHOW A PREDOMINANT PARASYMPATHETIC INFLUENCE ON THE HEART. 2016 14 2119 32 THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MALE PATIENTS WITH INSOMNIA. BACKGROUND: AN ESTIMATED 30-50% OF THE GENERAL POPULATION IS AFFECTED BY INSOMNIA AND 10% HAVE CHRONIC INSOMNIA. YOGA THERAPY IS BENEFICIAL IN SUCH DISORDERS AND IT HAS FEWER SIDE EFFECTS. AIM: THE AIM OF THIS STUDY WAS TO FIND OUT THE EFFECT OF YOGA THERAPY ON SELECTED PSYCHOLOGICAL VARIABLES AMONG MEN WITH INSOMNIA. METHODS: FORTY MALES WITH INSOMNIA WERE DIVIDED RANDOMLY INTO 2 GROUPS (THE EXPERIMENTAL AND THE CONTROL GROUPS). THE EXPERIMENTAL GROUP RECEIVED EIGHT WEEKS OF YOGA THERAPY, WHILE THE CONTROL GROUP DID NOT RECEIVE ANY THERAPY. THE PRE AND POST TREATMENT STRESS AND THE SELF CONFIDENCE SCORES WERE TAKEN. RESULTS: THERE WAS A SIGNIFICANT IMPROVEMENT IN THE STRESS SCORES AND THE SELF CONFIDENCE SCORES IN THE EXPERIMENTAL GROUP. THERE WERE NEITHER ANY SIDE EFFECTS NOR ANY DROP OUTS. CONCLUSION: WE CONCLUDE THAT YOGA IS AN EFFECTIVE TREATMENT OPTION FOR THE PATIENTS WITH INSOMNIA. THERE ARE NO MAJOR SIDE EFFECTS. 2013 15 2863 36 YOGA-BASED GUIDED RELAXATION REDUCES SYMPATHETIC ACTIVITY JUDGED FROM BASELINE LEVELS. 35 MALE VOLUNTEERS WHOSE AGES RANGED FROM 20 TO 46 YEARS WERE STUDIED IN TWO SESSIONS OF YOGA-BASED GUIDED RELAXATION AND SUPINE REST. ASSESSMENTS OF AUTONOMIC VARIABLES WERE MADE FOR 15 SUBJECTS, BEFORE, DURING, AND AFTER THE PRACTICES, WHEREAS OXYGEN CONSUMPTION AND BREATH VOLUME WERE RECORDED FOR 25 SUBJECTS BEFORE AND AFTER BOTH TYPES OF RELAXATION. A SIGNIFICANT DECREASE IN OXYGEN CONSUMPTION AND INCREASE IN BREATH VOLUME WERE RECORDED AFTER GUIDED RELAXATION (PAIRED T TEST). THERE WERE COMPARABLE REDUCTIONS IN HEART RATE AND SKIN CONDUCTANCE DURING BOTH TYPES OF RELAXATION. DURING GUIDED RELAXATION THE POWER OF THE LOW FREQUENCY COMPONENT OF THE HEART-RATE VARIABILITY SPECTRUM REDUCED, WHEREAS THE POWER OF THE HIGH FREQUENCY COMPONENT INCREASED, SUGGESTING REDUCED SYMPATHETIC ACTIVITY. ALSO, SUBJECTS WITH A BASELINE RATIO OF LF/HF > 0.5 SHOWED A SIGNIFICANT DECREASE IN THE RATIO AFTER GUIDED RELAXATION, WHILE SUBJECTS WITH A RATIO < OR = 0.5 AT BASELINE SHOWED NO SUCH CHANGE. THE RESULTS SUGGEST THAT SYMPATHETIC ACTIVITY DECREASED AFTER GUIDED RELAXATION BASED ON YOGA, DEPENDING ON THE BASELINE LEVELS. 2002 16 795 35 EFFECT OF YOGA INTERVENTION IN THE MANAGEMENT OF HYPERTENSION: A PREVENTIVE TRIAL. BACKGROUND: NONCOMMUNICABLE DISEASES ARE ON THE RISE IN INDIA. HYPERTENSION IS ONE OF THE MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASES AND ALSO LABELED AS A CHRONIC LIFESTYLE DISORDER. HENCE, NON-PHARMACOLOGICAL INTERVENTIONS LEADING TO LIFESTYLE MODIFICATIONS ARE OF UTMOST IMPORTANCE TO CONTROL AND PREVENT HYPERTENSION. THIS TRIAL AIMS TO IMPLEMENT YOGA INTERVENTION TO THE EXPERIMENTAL GROUP IN ADDITION TO MEDICINES, ADVICE ON DIET AND PHYSICAL ACTIVITY AND TO COMPARE BLOOD PRESSURE AND PERCEIVED STRESS SCORES WITH THE CONTROL GROUP. METHODS: IT WAS AN OPEN-LABEL, TWO-ARMED, NON-RANDOMIZED CONTROLLED TRIAL, CONDUCTED AT A TERTIARY CARE CENTER ON 145 PATIENTS WITH HYPERTENSION: 73 IN THE INTERVENTION GROUP AND 72 IN THE CONTROL GROUP. THE INTERVENTION GROUP RECEIVED YOGA INTERVENTION FOR A PERIOD OF 4 MONTHS ON A WEEKLY BASIS ALONG WITH ADVICE ON PHYSICAL ACTIVITY, DIET, AND ROUTINE MEDICINES. THE CONTROL GROUP DID NOT RECEIVE YOGA INTERVENTION. RESULTS: THE MEAN AGE OF THE PARTICIPANTS WAS 51.3 +/- 9.4, FEMALES (58.2%) OUTNUMBERED MALES (41.3%). FOLLOWING THE INTERVENTION, PERCEIVED STRESS SCORE AND BLOOD PRESSURE SHOWED A SIGNIFICANT REDUCTION BETWEEN TWO GROUPS (P < 0.001). ALSO, PERCEIVED STRESS AND BLOOD PRESSURE WERE FOUND TO BE REDUCED SIGNIFICANTLY WITHIN BOTH GROUPS (P < 0.001). CONCLUSIONS: YOGA PROVES TO BE AN EFFECTIVE, SAFE, AND LESS EXPENSIVE ADJUNCT THERAPY FOR HYPERTENSION MANAGEMENT. YOGA WAS ALSO FOUND TO BE EFFECTIVE IN REDUCING THE LEVEL OF STRESS. DIET MODIFICATION AND PHYSICAL ACTIVITY HAVE GOT AN IMPORTANT ROLE TO PLAY IN THE CONTROL AND PREVENTION OF HYPERTENSION. 2021 17 716 40 EFFECT OF INTEGRATED YOGA PRACTICES ON IMMUNE RESPONSES IN EXAMINATION STRESS - A PRELIMINARY STUDY. BACKGROUND: STRESS IS OFTEN ASSOCIATED WITH AN INCREASED OCCURRENCE OF AUTONOMIC, CARDIOVASCULAR, AND IMMUNE SYSTEM PATHOLOGY. THIS STUDY WAS DONE TO EVALUATE THE IMPACT OF STRESS ON PSYCHOLOGICAL, PHYSIOLOGICAL PARAMETERS, AND IMMUNE SYSTEM DURING MEDICAL TERM -ACADEMIC EXAMINATION AND THE EFFECT OF YOGA PRACTICES ON THE SAME. MATERIALS AND METHODS: THE STUDY WAS CARRIED OUT ON SIXTY FIRST-YEAR MBBS STUDENTS RANDOMLY ASSIGNED TO YOGA GROUP AND CONTROL GROUP (30 EACH). THE YOGA GROUP UNDERWENT INTEGRATED YOGA PRACTICES FOR 35 MINUTES DAILY IN THE PRESENCE OF TRAINED YOGA TEACHER FOR 12 WEEKS. CONTROL GROUP DID NOT UNDERGO ANY KIND OF YOGA PRACTICE OR STRESS MANAGEMENT. PHYSIOLOGICAL PARAMETERS LIKE HEART RATE, RESPIRATORY RATE, AND BLOOD PRESSURE WERE MEASURED. GLOBAL ASSESSMENT OF RECENT STRESS SCALE AND SPIELBERGERS STATE ANXIETY SCORE WERE ASSESSED AT BASELINE AND DURING THE EXAMINATION. SERUM CORTISOL LEVELS, IL-4, AND IFN-GAMMA LEVELS WERE DETERMINED BY ENZYME-LINKED IMMUNOSORBENT ASSAY TECHNIQUE. RESULT: IN THE YOGA GROUP, NO SIGNIFICANT DIFFERENCE WAS OBSERVED IN PHYSIOLOGICAL PARAMETERS DURING THE EXAMINATION STRESS, WHEREAS IN THE CONTROL GROUP, A SIGNIFICANT INCREASE WAS OBSERVED. LIKEWISE, THE INDICATORS OF PSYCHOLOGICAL STRESS SHOWED HIGHLY SIGNIFICANT DIFFERENCE IN CONTROL GROUP COMPARED WITH SIGNIFICANT DIFFERENCE IN YOGA GROUP. DURING THE EXAMINATION, THE INCREASE IN SERUM CORTICAL AND DECREASE IN SERUM IFN-GAMMA IN YOGA GROUP WAS LESS SIGNIFICANT (P<0.01) THAN IN THE CONTROL GROUP (P<0.001). BOTH THE GROUPS DEMONSTRATED AN INCREASE IN SERUM IL-4 LEVELS, THE CHANGES BEING INSIGNIFICANT FOR THE DURATION OF THE STUDY. CONCLUSION: YOGA RESISTS THE AUTONOMIC CHANGES AND IMPAIRMENT OF CELLULAR IMMUNITY SEEN IN EXAMINATION STRESS. 2011 18 1835 22 PSYCHOPHYSIOLOGICAL CHANGES AT THE TIME OF EXAMINATION IN MEDICAL STUDENTS BEFORE AND AFTER THE PRACTICE OF YOGA AND RELAXATION. THE EFFECT OF YOGA AND RELAXATION CHANGES IN PSYCHOPHYSIOLOGICAL PARAMETERS IN RESPONSE TO THE STRESS OF EXAMINATION IN 75 MEDICAL STUDENTS WAS STUDIED. INITIALLY FIVE PARAMETERS (ANXIETY LEVEL, HEART RATE, BLOOD PRESSURE, GALVANIC SKIN RESISTANCE AND CHOICE REACTION TIME) WERE RECORDED, A MONTH BEFORE THE EXAMINATION AND ON THE DAY OF EXAMINATION. STUDENTS WERE THEN RANDOMLY DIVIDED INTO 3 GROUP OF 25 EACH. ONE GROUP PRACTICED YOGA (GROUP- Y), AND ANOTHER GROUP PRACTICED RELAXATION (GROUP-R) REGULARLY FOR THREE MONTHS. THE THIRD GROUP WAS CONTROL GROUP (GROUP-C). ALL THE PARAMETERS WERE RECORDED AFTER THE CHANGES IN ANXIETY LEVEL, HEART RATE, BLOOD PRESSURE, AND GALVANIC SKIN RESISTANCE IN RESPONSE TO STRESS OF EXAMINATION WERE SIGNIFICANTLY ATTENUATED AND THERE WAS SIGNIFICANT IMPROVEMENT IN CHOICE REACTION TIME IN GROUP-Y AND GROUP-R AS COMPARED TO GROUP-C AFTER YOGA AND RELAXATION. 1998 19 845 27 EFFECT OF YOGA ON PULSE RATE AND BLOOD PRESSURE AMONG WOMEN. OBJECTIVES: CHANGE IN THE PAST FEW DECADES IN HUMAN LIFE STYLE, NOWADAYS INTERNATIONAL HEALTH ORGANIZATIONS, I.E., WORLD HEALTH ORGANIZATION ARE ALSO FOCUSING ON PREVENTION ALONG WITH TREATMENT ASPECT OF CHRONIC ILLNESS. RESEARCHES FOCUS THAT WOMEN OF AGE GROUP 30-45 YEARS ARE AT INCREASED RISK FOR HYPERTENSION AND HEART DISEASE DUE TO INCREASED WEIGHT. YOGA IS AN EFFECTIVE METHOD TO CONTROL OUR PHYSIOLOGICAL VARIABLES LIKE BLOOD PRESSURE (BP), PULSE, ETC. THE MAIN AIM OF THIS STUDY WAS TO IDENTIFY THE EFFECTS OF YOGA ON PHYSIOLOGICAL VARIABLES. METHODS: THE STUDY WAS AN EXPERIMENTAL STUDY WITH TWO GROUP, PRETEST AND POSTTEST CONTROL GROUP, DESIGN, WHICH WAS CONDUCTED ON 40 FEMALE PARTICIPANTS. PRANAYAMA AND MEDITATION FOR A PERIOD OF 6 WEEKS WAS DONE BY THESE WOMEN. RESULTS: YOGA THERAPY SIGNIFICANTLY REDUCED THE BP (0.000*) AND PULSE RATE (0.000*) OF WOMEN, WHICH WAS ALSO STATISTICALLY PROVED. CONCLUSIONS: YOGA THERAPY CAN BE AN EFFECTIVE METHOD TO CONTROL BP AND PULSE RATE OF PATIENTS WITH CHRONIC DISEASES. 2021 20 940 37 EFFECTS OF 6 MONTHS YOGA PROGRAM ON RENAL FUNCTIONS AND QUALITY OF LIFE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE. AIM: TO STUDY THE EFFECT OF 6 MONTHS YOGA PROGRAM IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE (CKD). MATERIALS AND METHODS: FIFTY-FOUR PATIENTS WITH CKD WERE STUDIED AND DIVIDED INTO TWO GROUPS (YOGA GROUP AND CONTROL GROUP) TO SEE THE EFFECT OF YOGA IN CKD. PATIENTS IN THE YOGA GROUP WERE OFFERED YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. SUBJECTS IN YOGA GROUP WERE TRAINED TO PERFORM SPECIFIC YOGIC ASANAS FOR AT LEAST 5 DAYS A WEEK FOR 40-60 MIN A DAY. REGULAR MONITORING OF BLOOD PRESSURE, RENAL FUNCTION, REQUIREMENT OF A NUMBER OF DIALYSIS, AND QUALITY OF LIFE (QOL) INDICATORS WERE DONE. FIFTY PATIENTS (YOGA - 25; CONTROL-25) COMPLETED 6 MONTHS FOLLOW-UP. RESULTS: IN YOGA GROUP, A SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, SIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE LEVELS, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF THE WORLD HEALTH ORGANIZATION QOL (AS ASSESSED BY BREF QOL SCORES) WERE SEEN AFTER 6 MONTHS. IN CONTROL GROUP, RISE OF BLOOD PRESSURE, DETERIORATION OF RENAL FUNCTION, AND QOL WERE OBSERVED. POSTSTUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A STATISTICALLY SIGNIFICANT REDUCTION OF BLOOD PRESSURE, NONSIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF QOL IN YOGA GROUP AS COMPARED TO CONTROL GROUP. FOR SUBJECTS IN YOGA GROUP, THE NEED FOR DIALYSIS WAS LESS WHEN COMPARED TO CONTROL GROUP ALTHOUGH THIS DIFFERENCE WAS STATISTICALLY INSIGNIFICANT. EXCEPT FOR INABILITY OF SOME PATIENTS TO PERFORM CERTAIN YOGIC ASANAS NO ADVERSE EFFECT WAS FOUND IN THE STUDY. CONCLUSION: SIX MONTHS YOGA PROGRAM IS SAFE AND EFFECTIVE AS AN ADJUVANT THERAPY IN IMPROVING RENAL FUNCTIONS AND QOL OF CKD PATIENTS. 2017